Physician profile
Luis Casas
NPI 1679541841
$30,424.87
in general payments reported to CMS, 2019-2025
9 companies · $17.06 in 2025
The $17.06 reported for 2025 was less than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $2,823 · 2021: $78.93 · 2022: $24.56 · 2023: $10K · 2024: $1,249 · 2025: $17.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,088 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,125 · Travel and Lodging: $913 · Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,088.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,125.00 |
| Travel and Lodging | $912.53 |
| Food and Beverage | $445.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $18,682.63 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $11,513.04 | 2023-2024 | |
| Dexcom, INC. | $77.70 | 2020-2025 | Dexcom G6 Transmitter |
| Tolmar Pharmaceuticals, INC. | $42.00 | 2021 | |
| Medtronic, INC. | $41.70 | 2021-2024 | Minimed 780g |
| Ipsen Biopharmaceuticals, INC | $30.92 | 2022-2023 | Sohonos |
| Ascensia Diabetes Care US INC. | $19.90 | 2020 | |
| Ferring Pharmaceuticals INC. | $16.98 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Casas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.